Company registration number 07788497 (England and Wales)
BRIGHTON AND HOVE THERAPIES LTD
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 SEPTEMBER 2025
PAGES FOR FILING WITH REGISTRAR
BRIGHTON AND HOVE THERAPIES LTD
CONTENTS
Page
Balance sheet
1
Notes to the financial statements
2 - 7
BRIGHTON AND HOVE THERAPIES LTD
BALANCE SHEET
AS AT 30 SEPTEMBER 2025
30 September 2025
- 1 -
2025
2024
Notes
£
£
£
£
Fixed assets
Tangible assets
4
705
1,057
Current assets
Debtors
5
9,329
9,181
Cash at bank and in hand
7,295
10,049
16,624
19,230
Creditors: amounts falling due within one year
6
(11,717)
(17,307)
Net current assets
4,907
1,923
Total assets less current liabilities
5,612
2,980
Creditors: amounts falling due after more than one year
7
-
0
(795)
Net assets
5,612
2,185
Capital and reserves
Called up share capital
8
100
100
Profit and loss reserves
5,512
2,085
Total equity
5,612
2,185

For the financial year ended 30 September 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

T he member has not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

The director acknowledges her responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The director of the company has elected not to include a copy of the profit and loss account within the financial statements.true

The financial statements were approved and signed by the director and authorised for issue on 13 May 2026
S Caws
Director
Company registration number 07788497 (England and Wales)
BRIGHTON AND HOVE THERAPIES LTD
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 SEPTEMBER 2025
- 2 -
1
Accounting policies
Company information

Brighton and Hove Therapies Ltd is a private company limited by shares incorporated in England and Wales. The registered office is 1 The Offices, 10 Fleet Street, Brighton, East Sussex, BN1 4ZE.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary a mounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

1.2
Turnover

Turnover is recognised at the fair value of the consideration received or receivable for services provided in the normal course of business, and is shown net of VAT and other sales related taxes. The fair value of consideration takes into account trade discounts, settlement discounts and volume rebates.

Revenue from contracts for the provision of professional services is recognised by reference to the stage of completion when the stage of completion, costs incurred and costs to complete can be estimated reliably. The stage of completion is calculated by comparing costs incurred, mainly in relation to contractual hourly staff rates and materials, as a proportion of total costs. Where the outcome cannot be estimated reliably, revenue is recognised only to the extent of the expenses recognised that are recover able.

1.3
Intangible fixed assets - goodwill

Goodwill represents the excess of the cost of acquisition of unincorporated businesses over the fair value of net assets acquired. It is initially recognised as an asset at cost and is subsequently measured at cost less accumulated amortisation and accumulated impairment losses. Goodwill is considered to have a finite useful life and is amortised on a systematic basis over its expected life, which is 10 years.

For the purposes of impairment testing, goodwill is allocated to the cash-generating units expected to benefit from the acquisition. Cash-generating units to which goodwill has been allocated are tested for impairment at least annually, or more frequently when there is an indication that the unit may be impaired. If the recoverable amount of the cash-generating unit is less than the carrying amount of the unit, the impairment loss is allocated first to reduce the carrying amount of any goodwill allocated to the unit and then to the other assets of the unit pro-rata on the basis of the carrying amount of each asset in the unit.

1.4
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Leasehold improvements
Over term of lease (3 years)
Plant and equipment
20% Straight line
Fixtures and fittings
20% Straight line
Computers
25% Straight line

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

BRIGHTON AND HOVE THERAPIES LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 SEPTEMBER 2025
1
Accounting policies
(Continued)
- 3 -
1.5
Impairment of fixed assets

At each reporting period end date, the company reviews the carrying amounts of its tangible and intangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any). Where it is not possible to estimate the recoverable amount of an individual asset, the company estimates the recoverable amount of the cash-generating unit to which the asset belongs.

Recoverable amount is the higher of fair value less costs to sell and value in use. In assessing value in use, the estimated future cash flows are discounted to their present value using a pre-tax discount rate that reflects current market assessments of the time value of money and the risks specific to the asset for which the estimates of future cash flows have not been adjusted.

If the recoverable amount of an asset (or cash-generating unit) is estimated to be less than its carrying amount, the carrying amount of the asset (or cash-generating unit) is reduced to its recoverable amount. An impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the impairment loss is treated as a revaluation decrease.

Recognised impairment losses are reversed if, and only if, the reasons for the impairment loss have ceased to apply. Where an impairment loss subsequently reverses, the carrying amount of the asset (or cash-generating unit) is increased to the revised estimate of its recoverable amount, but so that the increased carrying amount does not exceed the carrying amount that would have been determined had no impairment loss been recognised for the asset (or cash-generating unit) in prior years. A reversal of an impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the reversal of the impairment loss is treated as a revaluation increase.

1.6
Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

1.7
Financial instruments

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets

Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

BRIGHTON AND HOVE THERAPIES LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 SEPTEMBER 2025
1
Accounting policies
(Continued)
- 4 -
Impairment of financial assets

Financial assets, other than those held at fair value through profit and loss, are assessed for indicators of impairment at each reporting end date.

Financial assets are impaired where there is objective evidence that, as a result of one or more events that occurred after the initial recognition of the financial asset, the estimated future cash flows have been affected. If an asset is impaired, the impairment loss is the difference between the carrying amount and the present value of the estimated cash flows discounted at the asset’s original effective interest rate. The impairment loss is recognised in profit or loss.

If there is a decrease in the impairment loss arising from an event occurring after the impairment was recognised, the impairment is reversed. The reversal is such that the current carrying amount does not exceed what the carrying amount would have been, had the impairment not previously been recognised. The impairment reversal is recognised in profit or loss.

Derecognition of financial assets

Financial assets are derecognised only when the contractual rights to the cash flows from the asset expire or are settled, or when the company transfers the financial asset and substantially all the risks and rewards of ownership to another entity, or if some significant risks and rewards of ownership are retained but control of the asset has transferred to another party that is able to sell the asset in its entirety to an unrelated third party.

Classification of financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

Basic financial liabilities

Basic financial liabilities, including creditors and bank loans, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future paymen ts discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. A m ounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

Derecognition of financial liabilities

Financial liabilities are derecognised when the company’s contractual obligations expire or are discharged or cancelled.

1.8
Equity instruments

Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

1.9
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

BRIGHTON AND HOVE THERAPIES LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 SEPTEMBER 2025
1
Accounting policies
(Continued)
- 5 -
Deferred tax

Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.

The carrying amount of deferred tax assets is reviewed at each reporting end date and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered. Deferred tax is calculated at the tax rates that are expected to apply in the period when the liability is settled or the asset is realised. Deferred tax is charged or credited in the profit and loss account, except when it relates to items charged or credited directly to equity, in which case the deferred tax is also dealt with in equity. Deferred tax assets and liabilities are offset when the company has a legally enforceable right to offset current tax assets and liabilities and the deferred tax assets and liabilities relate to taxes levied by the same tax authority.

1.10
Retirement benefits

Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.

1.11
Leases

Rentals payable under operating leases, including any lease incentives received, are charged to profit or loss on a straight line basis over the term of the relevant lease except where another more systematic basis is more representative of the time pattern in which economic benefits from the lease d asset are consumed.

2
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2025
2024
Number
Number
Total
1
1
3
Intangible fixed assets
Goodwill
£
Cost
At 1 October 2024 and 30 September 2025
500
Amortisation and impairment
At 1 October 2024 and 30 September 2025
500
Carrying amount
At 30 September 2025
-
0
At 30 September 2024
-
0
BRIGHTON AND HOVE THERAPIES LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 SEPTEMBER 2025
- 6 -
4
Tangible fixed assets
Leasehold improvements
Plant and equipment
Fixtures and fittings
Computers
Total
£
£
£
£
£
Cost
At 1 October 2024 and 30 September 2025
24,683
1,735
2,743
2,900
32,061
Depreciation and impairment
At 1 October 2024
24,683
1,735
2,743
1,843
31,004
Depreciation charged in the year
-
0
-
0
-
0
352
352
At 30 September 2025
24,683
1,735
2,743
2,195
31,356
Carrying amount
At 30 September 2025
-
0
-
0
-
0
705
705
At 30 September 2024
-
0
-
0
-
0
1,057
1,057
5
Debtors
2025
2024
Amounts falling due within one year:
£
£
Trade debtors
3,775
3,920
Prepayments and accrued income
3,896
3,288
7,671
7,208
Deferred tax asset
1,658
1,973
9,329
9,181
6
Creditors: amounts falling due within one year
2025
2024
£
£
Bank loans
797
1,141
Trade creditors
3,294
2,964
Corporation tax
1,662
1,950
Other taxation and social security
193
-
0
Other creditors
4,481
10,052
Accruals and deferred income
1,290
1,200
11,717
17,307
7
Creditors: amounts falling due after more than one year
2025
2024
£
£
Bank loans and overdrafts
-
0
795
BRIGHTON AND HOVE THERAPIES LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 SEPTEMBER 2025
- 7 -
8
Called up share capital
2025
2024
2025
2024
Ordinary share capital
Number
Number
£
£
Issued and fully paid
Ordinary shares of £1 each
100
100
100
100
9
Operating lease commitments
As lessee

At the reporting end date the company had outstanding commitments for future minimum lease payments under non-cancellable operating leases, as follows:

2025
2024
£
£
Total commitments
19,366
37,457
2025-09-30 2024-10-01 false false false 15 May 2026 CCH Software CCH Accounts Production 2026.100 No description of principal activity S Caws 07788497 2024-10-01 2025-09-30 07788497 2025-09-30 07788497 2024-09-30 07788497 core:LeaseholdImprovements 2025-09-30 07788497 core:PlantMachinery 2025-09-30 07788497 core:FurnitureFittings 2025-09-30 07788497 core:ComputerEquipment 2025-09-30 07788497 core:LeaseholdImprovements 2024-09-30 07788497 core:PlantMachinery 2024-09-30 07788497 core:FurnitureFittings 2024-09-30 07788497 core:ComputerEquipment 2024-09-30 07788497 core:CurrentFinancialInstruments core:WithinOneYear 2025-09-30 07788497 core:CurrentFinancialInstruments core:WithinOneYear 2024-09-30 07788497 core:WithinOneYear 2025-09-30 07788497 core:WithinOneYear 2024-09-30 07788497 core:AfterOneYear 2025-09-30 07788497 core:AfterOneYear 2024-09-30 07788497 core:ShareCapital 2025-09-30 07788497 core:ShareCapital 2024-09-30 07788497 core:RetainedEarningsAccumulatedLosses 2025-09-30 07788497 core:RetainedEarningsAccumulatedLosses 2024-09-30 07788497 core:ShareCapitalOrdinaryShareClass1 2025-09-30 07788497 core:ShareCapitalOrdinaryShareClass1 2024-09-30 07788497 bus:Director1 2024-10-01 2025-09-30 07788497 core:Goodwill 2024-10-01 2025-09-30 07788497 core:LeaseholdImprovements 2024-10-01 2025-09-30 07788497 core:PlantMachinery 2024-10-01 2025-09-30 07788497 core:FurnitureFittings 2024-10-01 2025-09-30 07788497 core:ComputerEquipment 2024-10-01 2025-09-30 07788497 2023-10-01 2024-09-30 07788497 core:Goodwill 2024-09-30 07788497 core:Goodwill 2025-09-30 07788497 core:Goodwill 2024-09-30 07788497 core:LeaseholdImprovements 2024-09-30 07788497 core:PlantMachinery 2024-09-30 07788497 core:FurnitureFittings 2024-09-30 07788497 core:ComputerEquipment 2024-09-30 07788497 2024-09-30 07788497 core:CurrentFinancialInstruments 2025-09-30 07788497 core:CurrentFinancialInstruments 2024-09-30 07788497 core:Non-currentFinancialInstruments 2025-09-30 07788497 core:Non-currentFinancialInstruments 2024-09-30 07788497 bus:OrdinaryShareClass1 2024-10-01 2025-09-30 07788497 bus:OrdinaryShareClass1 2025-09-30 07788497 bus:OrdinaryShareClass1 2024-09-30 07788497 bus:PrivateLimitedCompanyLtd 2024-10-01 2025-09-30 07788497 bus:SmallCompaniesRegimeForAccounts 2024-10-01 2025-09-30 07788497 bus:FRS102 2024-10-01 2025-09-30 07788497 bus:AuditExemptWithAccountantsReport 2024-10-01 2025-09-30 07788497 bus:FullAccounts 2024-10-01 2025-09-30 xbrli:pure xbrli:shares iso4217:GBP